Etiopathogenetic parallels and unresolved issues of pathogenesis of comorbidity COPD and metabolic syndrome (review)

The review analyzes the etiological and pathogenetic factors (including immunopathogenesis factors) of chronic obstructive pulmonary disease (COPD) and metabolic syndrome (MS), cites data on clinical and pathogenetic characteristics of combined pathology, emphasizes the commonality of risk factors a...

Full description

Bibliographic Details
Main Authors: Olga V. Voronkova, Tatyana V. Saprina, Ekaterina B. Bukreeva, Anastasia P. Zima
Format: Article
Language:English
Published: Endocrinology Research Centre 2020-12-01
Series:Ожирение и метаболизм
Subjects:
Online Access:https://www.omet-endojournals.ru/jour/article/view/12378
_version_ 1797204628110049280
author Olga V. Voronkova
Tatyana V. Saprina
Ekaterina B. Bukreeva
Anastasia P. Zima
author_facet Olga V. Voronkova
Tatyana V. Saprina
Ekaterina B. Bukreeva
Anastasia P. Zima
author_sort Olga V. Voronkova
collection DOAJ
description The review analyzes the etiological and pathogenetic factors (including immunopathogenesis factors) of chronic obstructive pulmonary disease (COPD) and metabolic syndrome (MS), cites data on clinical and pathogenetic characteristics of combined pathology, emphasizes the commonality of risk factors and individual links of pathogenesis in syntropy.The clinical and pathogenetic features of the comorbidity of COPD and MS are closely related to the severity of chronic “metabolic” inflammation induced by elements of adipose tissue. Functional and biochemical disorders recorded in metabolic syndrome (insulin resistance, hyperglycemia, dyslipidemia) are considered as factors contributing to dysfunction of the components of innate and adaptive immunity.The review formulates a number of unresolved issues of the pathogenesis of comorbid pathology, the study of which is necessary to search for the mutual aggravating effect of COPD and MS mechanisms. In view of the clinical and laboratory metabolic syndrome equivalents variety, the authors emphasize the relevance of future studies of the pathogenetic features of chronic inflammation associated with the comorbidity of the main components of metabolic syndrome and COPD, to develop effective methods of prevention and pathogenetic therapy of comorbid pathology.
first_indexed 2024-03-08T09:12:32Z
format Article
id doaj.art-c182900fd85747d784c40e9fc86840b6
institution Directory Open Access Journal
issn 2071-8713
2306-5524
language English
last_indexed 2024-04-24T08:38:15Z
publishDate 2020-12-01
publisher Endocrinology Research Centre
record_format Article
series Ожирение и метаболизм
spelling doaj.art-c182900fd85747d784c40e9fc86840b62024-04-16T16:16:12ZengEndocrinology Research CentreОжирение и метаболизм2071-87132306-55242020-12-0117329229810.14341/omet1237810848Etiopathogenetic parallels and unresolved issues of pathogenesis of comorbidity COPD and metabolic syndrome (review)Olga V. Voronkova0Tatyana V. Saprina1Ekaterina B. Bukreeva2Anastasia P. Zima3Siberian State Medical UniversitySiberian State Medical UniversitySiberian State Medical UniversitySiberian State Medical UniversityThe review analyzes the etiological and pathogenetic factors (including immunopathogenesis factors) of chronic obstructive pulmonary disease (COPD) and metabolic syndrome (MS), cites data on clinical and pathogenetic characteristics of combined pathology, emphasizes the commonality of risk factors and individual links of pathogenesis in syntropy.The clinical and pathogenetic features of the comorbidity of COPD and MS are closely related to the severity of chronic “metabolic” inflammation induced by elements of adipose tissue. Functional and biochemical disorders recorded in metabolic syndrome (insulin resistance, hyperglycemia, dyslipidemia) are considered as factors contributing to dysfunction of the components of innate and adaptive immunity.The review formulates a number of unresolved issues of the pathogenesis of comorbid pathology, the study of which is necessary to search for the mutual aggravating effect of COPD and MS mechanisms. In view of the clinical and laboratory metabolic syndrome equivalents variety, the authors emphasize the relevance of future studies of the pathogenetic features of chronic inflammation associated with the comorbidity of the main components of metabolic syndrome and COPD, to develop effective methods of prevention and pathogenetic therapy of comorbid pathology.https://www.omet-endojournals.ru/jour/article/view/12378comorbiditychronic obstructive pulmonary diseasemetabolic syndromechronic inflammationpathogenesis
spellingShingle Olga V. Voronkova
Tatyana V. Saprina
Ekaterina B. Bukreeva
Anastasia P. Zima
Etiopathogenetic parallels and unresolved issues of pathogenesis of comorbidity COPD and metabolic syndrome (review)
Ожирение и метаболизм
comorbidity
chronic obstructive pulmonary disease
metabolic syndrome
chronic inflammation
pathogenesis
title Etiopathogenetic parallels and unresolved issues of pathogenesis of comorbidity COPD and metabolic syndrome (review)
title_full Etiopathogenetic parallels and unresolved issues of pathogenesis of comorbidity COPD and metabolic syndrome (review)
title_fullStr Etiopathogenetic parallels and unresolved issues of pathogenesis of comorbidity COPD and metabolic syndrome (review)
title_full_unstemmed Etiopathogenetic parallels and unresolved issues of pathogenesis of comorbidity COPD and metabolic syndrome (review)
title_short Etiopathogenetic parallels and unresolved issues of pathogenesis of comorbidity COPD and metabolic syndrome (review)
title_sort etiopathogenetic parallels and unresolved issues of pathogenesis of comorbidity copd and metabolic syndrome review
topic comorbidity
chronic obstructive pulmonary disease
metabolic syndrome
chronic inflammation
pathogenesis
url https://www.omet-endojournals.ru/jour/article/view/12378
work_keys_str_mv AT olgavvoronkova etiopathogeneticparallelsandunresolvedissuesofpathogenesisofcomorbiditycopdandmetabolicsyndromereview
AT tatyanavsaprina etiopathogeneticparallelsandunresolvedissuesofpathogenesisofcomorbiditycopdandmetabolicsyndromereview
AT ekaterinabbukreeva etiopathogeneticparallelsandunresolvedissuesofpathogenesisofcomorbiditycopdandmetabolicsyndromereview
AT anastasiapzima etiopathogeneticparallelsandunresolvedissuesofpathogenesisofcomorbiditycopdandmetabolicsyndromereview